➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKesson
Colorcon
McKinsey
Johnson and Johnson

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205935


Email this page to a colleague

« Back to Dashboard

NDA 205935 describes FULVESTRANT, which is a drug marketed by Accord Hlthcare, Amneal, Auromedics Pharma, Chia Tai Tianqing, Dr Reddys, Glenmark Pharms Inc, Hbt Labs Inc, Sagent Pharms Inc, Sandoz Inc, Fresenius Kabi Usa, and Teva Pharms Usa Inc, and is included in eleven NDAs. It is available from thirteen suppliers. There are three patents protecting this drug. Additional details are available on the FULVESTRANT profile page.

The generic ingredient in FULVESTRANT is fulvestrant. There are twelve drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the fulvestrant profile page.
Summary for 205935
Tradename:FULVESTRANT
Applicant:Sandoz Inc
Ingredient:fulvestrant
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 205935
Suppliers and Packaging for NDA: 205935
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FULVESTRANT fulvestrant INJECTABLE;INTRAMUSCULAR 205935 ANDA Sandoz Inc 0781-3079 0781-3079-12 2 SYRINGE, GLASS in 1 CARTON (0781-3079-12) > 5 mL in 1 SYRINGE, GLASS (0781-3079-01)
FULVESTRANT fulvestrant INJECTABLE;INTRAMUSCULAR 205935 ANDA Northstar RxLLC 16714-118 16714-118-02 2 SYRINGE, GLASS in 1 CARTON (16714-118-02) > 5 mL in 1 SYRINGE, GLASS (16714-118-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAMUSCULARStrength50MG/ML
Approval Date:May 14, 2019TE:AORLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Johnson and Johnson
Express Scripts
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.